LAZARD ASSET MANAGEMENT LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 384 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$32,870
-24.0%
860,474
-28.2%
0.04%
-15.1%
Q2 2023$43,235
+61.8%
1,198,667
+71.3%
0.05%
+51.4%
Q1 2023$26,717
+5.4%
699,604
+57.0%
0.04%0.0%
Q4 2022$25,351
-99.9%
445,541
-8.6%
0.04%
+25.0%
Q3 2022$19,273,000
+7200.4%
487,443
+8020.0%
0.03%
Q2 2022$264,000
+3671.4%
6,003
+3010.4%
0.00%
Q1 2022$7,000
-94.5%
193
-93.9%
0.00%
Q4 2021$127,000
+23.3%
3,177
+25.2%
0.00%
Q3 2021$103,000
-15.6%
2,538
-6.0%
0.00%
Q2 2021$122,000
+17.3%
2,700
+7.9%
0.00%
Q1 2021$104,000
+20.9%
2,502
+23.7%
0.00%
Q4 2020$86,000
+62.3%
2,0220.0%0.00%
Q3 2020$53,000
-98.7%
2,022
-98.7%
0.00%
-100.0%
Q2 2020$4,041,000
+9084.1%
150,740
+5877.0%
0.01%
Q4 2019$44,000
+528.6%
2,522
+443.5%
0.00%
Q3 2019$7,0004640.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Third Security, LLC 14,092,771$256,066,00016.64%
BB BIOTECH AG 8,247,860$149,864,0003.97%
MSD Partners, L.P. 2,245,000$40,792,0003.07%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 428,633$5,969,0002.84%
First Light Asset Management, LLC 885,523$16,090,0002.60%
SNYDER CAPITAL MANAGEMENT L P 2,387,350$43,378,0001.93%
Sterling Global Strategies LLC 22,000$400,0001.74%
Taylor Wealth Management Partners 221,380$4,022,0001.71%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,228,399$167,680,0001.68%
DOHENY ASSET MANAGEMENT /CA 124,393$2,260,0001.18%
View complete list of HALOZYME THERAPEUTICS INC shareholders